‘Method C’ ⇒ risky [Two-Stage / GS Designs]

posted by Helmut Homepage – Vienna, Austria, 2019-09-19 16:15  – Posting: # 20622
Views: 1,204

Hi Elena,

» This is our first experience in conducting such studies, so we are quite excited. :lookaround:

Keep in mind that it might also be the first experience for the experts of the agencies you are aiming at. Possibly they have heard about the skeptic attitudes of European assessors towards ‘Method C’. Consider ‘Method B’ instead. See the end of this post for a comparison of power. What will it help to have (maybe) two subject less in the second stage and a study which is not accepted? I warned you. :cool:

Cheers,
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. ☼
Science Quotes

Complete thread:

Activity
 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
20,037 posts in 4,233 threads, 1,378 registered users;
online 12 (2 registered, 10 guests [including 5 identified bots]).
Forum time (Europe/Vienna): 14:21 CET

Maturity is the capacity to endure uncertainty.    John Finley

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5